Childhood cancer survival rates have soared in recent years. However, a new challenge emerges: the rising prevalence of obesity among young cancer survivors. This review explores the complex relationship between pediatric oncology and obesity, highlighting its impact on long-term health. We delve into potential causes, associated health risks, and strategies for general pediatricians to address this growing concern. By equipping themselves with the right knowledge and tools, general pediatricians can play a crucial role in promoting healthy weight management for childhood cancer survivors.
The fight against childhood cancer has seen remarkable progress, with survival rates reaching new highs. Yet, a new battle looms on the horizon - the growing issue of obesity in childhood cancer survivors. This review sheds light on this critical public health concern, empowering general pediatricians to become champions of survivor health.
While the exact reasons are still under investigation, several factors contribute to the increased risk of obesity in pediatric cancer survivors:
Treatment-related side effects: Certain cancer treatments, like corticosteroids, can lead to weight gain and metabolic changes.
Reduced physical activity: The demands of treatment and recovery can often limit a child's ability to engage in physical activity, a key factor in maintaining a healthy weight.
Psychological factors: The emotional toll of battling cancer can lead to comfort eating or a decrease in motivation for exercise.
Excess weight in childhood cancer survivors is associated with a range of health complications:
Increased risk of chronic diseases: Obesity can heighten the risk of developing cardiovascular diseases, type 2 diabetes, and some cancers later in life.
Musculoskeletal problems: Carrying extra weight can lead to joint pain and other musculoskeletal issues.
Mental health concerns: Obesity can contribute to low self-esteem and depression in survivors.
General pediatricians play a vital role in the long-term care of childhood cancer survivors. Here's how they can address the issue of obesity:
Regular weight monitoring: Tracking weight changes and body mass index (BMI) can help identify potential problems early on.
Nutritional counseling: Providing personalized dietary advice tailored to the survivor's needs and preferences is essential.
Promoting physical activity: Encouraging survivors to engage in age-appropriate physical activities based on their physical capacity.
Collaboration with specialists: Working with oncologists, nutritionists, and psychologists can create a comprehensive support system.
The rise of obesity in childhood cancer survivors presents a significant public health challenge. However, through early intervention, education, and a collaborative approach, general pediatricians can empower survivors to embrace healthy lifestyles and optimize their long-term health. By understanding the complex link between pediatric oncology and obesity, we can work together to ensure a brighter, healthier future for young cancer survivors.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
2.
According to new studies, some cancer patients can safely forego radiation therapy.
3.
According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.
4.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
5.
Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk
1.
Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy
2.
Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored
3.
Community-Based Cancer Survivorship Support Systems
4.
Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
Navigating the Complexities of Ph Negative ALL - Part III
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation